School of Medicine, Pontificia Universidad Javeriana, Cra 7 # 40-62 piso 7, 110231, Bogotá, Colombia.
Internal Medicine Department, Hospital Universitario San Ignacio, Bogotá, Colombia.
Int Urogynecol J. 2023 Jun;34(6):1195-1201. doi: 10.1007/s00192-022-05320-4. Epub 2022 Aug 22.
Complicated urinary tract infection (cUTI) is highly prevalent and costly for health systems. The impact of the indwelling urinary catheter on etiologic agents and clinical outcomes has been poorly studied in Latin America.
Cross-sectional study including patients with cUTI, with positive urine culture, treated at Hospital Universitario San Ignacio, Bogotá (Colombia) between 2017 and 2020. Clinical and microbiologic characteristics, treatments and outcomes are explored, comparing those with and without indwelling urinary catheter.
Seven hundred thirty-five patients with non-catheter-associated cUTI (NC-cUTI) and 165 with catheter-associated cUTI (CAUTI) were included. CAUTI group had a higher proportion of recurrent UTI (18% vs 33.3%, p < 0.001), ICU requirement (2.7% vs 8.5%, p < 0.001), longer hospital stay (6 vs 10 days, p < 0.001) and > 30 days unplanned readmission rate (5.8% vs 10.3%, p < 0.001). In the same group, we found a higher frequency of Pseudomonas spp (2.6% vs 9.4%, p < 0.001), Enterococcus spp. (2.4% vs 3.3%, p = 0.016), Serratia marcescens (0.6% vs 3.3%, p < 0.001) and Citrobacter freundii (0.5% vs 5.7%, p < 0.001). It implied a higher number of patients treated with fourth-generation cephalosporins (1.4% vs 4.8%, p = 0.004), ertapenem (32.9% vs 41.8%, p = 0.027) and carbapenems associated with a second antibiotic (1.9% vs 8.5%, p < 0.001).
Patients with CAUTI have a higher frequency of resistant germs, require greater use of resources and have worse clinical outcomes than patients who do not require such devices. Measures should be strengthened to minimize its use, in both the hospital and outpatient setting.
复杂性尿路感染(cUTI)在卫生系统中患病率高且费用昂贵。留置导尿管对拉丁美洲的病原体和临床结局的影响研究甚少。
对 2017 年至 2020 年在波哥大圣伊格纳西奥大学医院接受治疗的 cUTI 患者进行了横断面研究,这些患者的尿液培养阳性。对临床和微生物学特征、治疗和结局进行了探讨,并比较了有和无留置导尿管的患者。
共纳入 735 例非导管相关性 cUTI(NC-cUTI)和 165 例导管相关性 cUTI(CAUTI)患者。CAUTI 组复发性尿路感染的比例较高(18% vs 33.3%,p<0.001),需要 ICU 治疗的比例较高(2.7% vs 8.5%,p<0.001),住院时间较长(6 天 vs 10 天,p<0.001),无计划 30 天以上再入院率较高(5.8% vs 10.3%,p<0.001)。在同一组中,我们发现假单胞菌属(2.6% vs 9.4%,p<0.001)、肠球菌属(2.4% vs 3.3%,p=0.016)、粘质沙雷氏菌(0.6% vs 3.3%,p<0.001)和弗氏柠檬酸杆菌(0.5% vs 5.7%,p<0.001)的发生频率更高。这意味着需要使用第四代头孢菌素(1.4% vs 4.8%,p=0.004)、厄他培南(32.9% vs 41.8%,p=0.027)和碳青霉烯类药物联合第二种抗生素治疗的患者比例更高(1.9% vs 8.5%,p<0.001)。
与不需要此类设备的患者相比,CAUTI 患者的耐药菌发生频率更高,需要更多的资源,临床结局更差。应在医院和门诊环境中加强措施,尽量减少留置导尿管的使用。